why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: May 07, 2025

Clinical Trial: A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Chronic Liver Disease

Study Type: INTERVENTIONAL


Official Title: An Open-label, Fixed Sequence Study in Healthy Participants to Assess the Effect of Multiple Doses of AZD2389 on the Pharmacokinetics of Midazolam, Caffeine, and Bupropion

Brief Summary: The purpose of this study is to measure the effect of multiple doses of AZD2389 on the pharmacokinetics (PK) of midazolam, caffeine, and bupropion in healthy participants.

Read more